CEACAM5 and neoplasm: A predictive nomogram including the CEA, ALT, tumor size and biology, the presence of extrahepatic disease, and albumin level was highly predictive of 12-month patient survival after TARE of CRLM in heavily pretreated patients in the chemorefractory stage [168].